Home › Funds › Pavaki Capital Management LLC › MIST

Pavaki Capital Management LLC position in MIST

MILESTONE PHARMACEUTICALS IN · Health Care

Pavaki Capital Management LLC reported holding 9,337,848 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 3.38% of its reported portfolio and ranking #8 among its reported holdings. Pavaki Capital Management LLC has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)9.34M sh
Reported value held$8.08M
Portfolio Weight3.38%
First reportedQ4 2025
Last changeAdd
Updated2026-10-26

Last updated: 2026-10-26 · Source: SEC EDGAR Form 13F-HR

How Pavaki Capital Management LLC's MIST position evolved

Pavaki Capital Management LLC first disclosed a stake in MIST in Q4 2025 at 8,498,915 shares (US$17.2M). Across 4 filings, Pavaki Capital Management LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 9,337,848 shares valued at US$8.1M — an increase of 270,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 8.50M $17.17M New
Q1 2026 9.06M $10.78M Add
Q2 2026 9.07M $12.15M Hold
Q3 2026 9.34M $8.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIST and 13F data

MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 30 other funds we track also report a position in MIST — the largest reported positions include Propel Bio Management, LLC (US$10.0M), Simplify Asset Management Inc. (US$4.5M), Kalehua Capital Management LLC (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIST

All MIST fund holders →

FAQ

How long has Pavaki Capital Management LLC held MIST?

Pavaki Capital Management LLC has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Pavaki Capital Management LLC's current position in MIST?

As of Q3 2026, Pavaki Capital Management LLC holds 9.34M shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $8.08M, representing 3.38% of its reported portfolio and ranking #8.

Has Pavaki Capital Management LLC been buying or selling MIST?

In the latest 13F filing (Q3 2026), Pavaki Capital Management LLC increased its position in MIST.

Which other funds hold MIST?

Other major institutional holders of MIST include Propel Bio Management, LLC, Simplify Asset Management Inc., Kalehua Capital Management LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.